Research and experimental development on natural sciences and engineering
AGIANA PHARMACEUTICALS AS
Revenue 2024
NOK 535,000
Operating profit
NOK −4.7m
Equity
NOK 13.4m
Incorporated
2021
Share capital
NOK 37,000
Organisation
Established
2021-05-20
Industry code
72.100
Legal form
AS
Group structure
Eier · 49.1%
DART NEURO SCIENCE LLC
Company
AGIANA PHARMACEUTICALS AS
No subsidiaries
Industry and activity
- NACE
- 72.100 — Research and experimental development on natural sciences and engineering
- Sector
- Private non-financial incorporated enterprises
- Activity
- Utvikling og kommersialisering av legemidler.
Business address
Gaustadalléen 21, 0349 OSLO
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.